http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011520819-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2009-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011520819-A |
| titleOfInvention | Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines |
| abstract | The present invention relates to substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines and methods for their preparation, as well as diseases, in particular blood diseases, preferably leukopenia and neutrophils It relates to their use for the manufacture of a medicament for the treatment and / or prevention of reduction. Formula (I), wherein A is a group of formula (II), (III), (IV), (V) or (VI) wherein # 1 is a heterocycle substituted by R 1 # 2 represents the point of attachment to the carbon atom to which R 13 is attached, # 3 represents a represents the point of attachment to the carbon atom to which R 4 is attached). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010532772-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010521506-A |
| priorityDate | 2008-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 607.